SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?


To: Jerry Olson who wrote (100853)6/6/2000 12:33:00 PM
From: AF  Read Replies (1) | Respond to of 120523
 
GEEEEEEZZZZZ.... don't tell me I'm going to have to get back into GENE and CEGE!!!???? ;^)



To: Jerry Olson who wrote (100853)6/6/2000 12:38:00 PM
From: nokomis  Respond to of 120523
 
well my baby Angoss is up 16% and should continue to do well leading up to earnings at end of month .. not exactly as exciting as your breakouts, but at $2.10, it's down from last quarter high of $8 or so despite continued growth!

ANC.V is back on the radar...

biz.yahoo.com



To: Jerry Olson who wrote (100853)6/6/2000 6:47:00 PM
From: sam  Read Replies (1) | Respond to of 120523
 
Tuesday June 6, 6:16 pm Eastern Time

Immunex's Enbrel wins US approval for new use

biz.yahoo.com

Trading up 6 after hours to 38 and change.